Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Regdanvimab Authorized Experimental Antiviral Mar/04/2022 5 4
Nirmatrelvir Emergency use authorization Experimental Antiviral Feb/15/2022 5 0
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
mRNA-1273 Emergency use authorization Experimental Vaccine Feb/03/2022 25 0
Ad26.COV2.S Emergency use authorization Experimental Vaccine Feb/03/2022 8 1
N(4)-Hydroxycytidine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
Etesevimab Emergency use authorization Experimental Antiviral Jan/26/2022 2 11
Imdevimab Emergency use authorization Experimental Antiviral Jan/26/2022 9 8
Cilgavimab Emergency use authorization Experimental Antiviral Jan/26/2022 8 3
Casirivimab Emergency use authorization Experimental Antiviral Jan/26/2022 4 11